Aryeh Jason
- SEC CIK
- 0001376960
In the past year, 2 open-market purchase filings worth $37.5K and 1 sale filing worth $1.25M.
Current role at each company
- OBIO Orchestra BioMed Holdings, Inc.Directoras of Jun 25, 2026
- LGND Ligand Pharmaceuticals IncDirectoras of Jun 12, 2026
- LFCR Lifecore Biomedical, Inc.Directoras of Jun 5, 2026
- ANEB Anebulo Pharmaceuticals, Inc.Directoras of Apr 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $37.5K
- 2 filings
- Sold
- $1.25M
- 1 filing
- Net
- −$1.21M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Aryeh Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LGND Ligand Pharmaceuticals Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2025 (view filing) | Sep 23 | 1 day | Aryeh JasonDirector | SSale | −10.0K | $170.81 | −$1.71M | −12.6%69.3K after | 3 lots |
| Jun 12, 2026 (view filing) | Jun 10-11 | 2 days | Aryeh JasonDirector | SSale | −5.00K | $250.00 | −$1.25M | −4.6%102.6K after | 2 lots |
OBIO Orchestra BioMed Holdings, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 (view filing) | Sep 19 | Same day | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +1.00K | $2.45 | +$2.45K | +0.9%108.5K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +8.97K | $3.90 | +$35.0K | +8.3%117.5K after | |
| May 20, 2026 (view filing) | May 18 | 2 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +665 | $3.75 | +$2.49K | +0.6%118.1K after |